title: Chronic administration of bacopa monniera increases BDNF protein and mRNA expressions: a study in chronic unpredictable stress induced animal model of depression.
abstract: OBJECTIVE
  The present study aimed to investigate whether graded doses of Bacopa Monniera (BM) extract could produce antidepressant-like effects in chronic unpredictable stress (CUS) induced depression in rats and its possible mechanism(s).
  
  
  METHODS
  Rats were subjected to an experimental setting of CUS. The effect of BM extract treatment in CUS-induced depression was examined using behavioral tests including the sucrose consumption, open field test and shuttle box escape test. The mechanism underlying the antidepressant-like action of BM extract was examined by measuring brain-derived neurotrophic factor (BDNF) protein and mRNA expression in brain tissues of CUS-exposed rats.
  
  
  RESULTS
  Exposure to CUS for 4 weeks caused depression-like behavior in rats, as indicated by significant decreases in sucrose consumption, locomotor activity and escape latency. In addition, it was found that BDNF protein and mRNA levels in the hippocampus and frontal cortex were lower in CUS-treated rats, as compared to controls. Daily administration of the graded doses of BM extract during the 4-week period of CUS significantly suppressed behavioral changes and attenuated the CUS-induced decrease in BDNF protein and mRNA levels in the hippocampus and frontal cortex.
  
  
  CONCLUSIONS
  The results suggest that BM extract alleviates depression induced by CUS. Present study also confirms that 80-120 mg/kg doses of BM extract have significantly higher antidepressant-like activity.
authors.affiliation: Department of Physiology, Raja Peary Mohan College, Uttarpara, Hooghly, West Bengal, India.
authors.forename: Ritabrata
authors.initials: R
authors.lastname: Banerjee
authors.affiliation: Department of Physiology, Raja Peary Mohan College, Uttarpara, Hooghly, West Bengal, India.
authors.forename: Somoday
authors.initials: S
authors.lastname: Hazra
authors.affiliation: Department of Instrumentation Science, Jadavpur University, Calcutta, West Bengal, India.
authors.forename: Anup Kumar
authors.initials: AK
authors.lastname: Ghosh
authors.affiliation: Department of Physiology, Raja Peary Mohan College, Uttarpara, Hooghly, West Bengal, India.
authors.forename: Amal Chandra
authors.initials: AC
authors.lastname: Mondal
keywords: Antidepressant; BDNF; Bacopa monniera; Chronic unpredictable stress; Open field test; Shuttle box escape test; Sucrose consumption; TrkB
references.citation: Psychopharmacology (Berl). 1997 Dec;134(4):319-29
references.pmid: 9452163
references.citation: Neurobiol Dis. 2008 Aug;31(2):278-85
references.pmid: 18586506
references.citation: Brain Res Bull. 2008 Sep 5;77(1):8-12
references.pmid: 18579108
references.citation: J Ethnopharmacol. 2009 Jul 15;124(2):316-20
references.pmid: 19375493
references.citation: Eur Neuropsychopharmacol. 2004 Dec;14 Suppl 5:S481-90
references.pmid: 15550346
references.citation: Life Sci. 2007 Mar 20;80(15):1373-81
references.pmid: 17289085
references.citation: J Ethnopharmacol. 2008 Sep 26;119(2):272-5
references.pmid: 18687393
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1256-60
references.pmid: 16647794
references.citation: Brain Res Bull. 2009 Mar 30;78(6):267-9
references.pmid: 19111910
references.citation: Pharmacol Biochem Behav. 1997 Jan;56(1):131-7
references.pmid: 8981620
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):281-5
references.pmid: 19110026
references.citation: Neuropsychobiology. 2008;57(4):194-9
references.pmid: 18679038
references.citation: Phytomedicine. 2005 Apr;12(4):305-17
references.pmid: 15898709
references.citation: Curr Opin Pharmacol. 2007 Feb;7(1):18-21
references.pmid: 17049922
references.citation: J Psychiatr Res. 2009 Feb;43(5):512-8
references.pmid: 18707693
references.citation: Neurosci Biobehav Rev. 1981 Summer;5(2):259-64
references.pmid: 7196556
references.citation: Psychopharmacol Bull. 2001 Spring;35(2):5-49
references.pmid: 12397885
references.citation: Neuropsychobiology. 2005;52(2):90-110
references.pmid: 16037678
references.citation: Eur J Pharmacol. 2000 Jun 30;399(1):43-7
references.pmid: 10876021
references.citation: Biol Psychiatry. 2003 Jul 1;54(1):70-5
references.pmid: 12842310
references.citation: Psychiatry Investig. 2010 Dec;7(4):231-5
references.pmid: 21253405
references.citation: Neurosci Res. 2005 Oct;53(2):129-39
references.pmid: 16024125
references.citation: Epilepsy Behav. 2006 Feb;8(1):102-14
references.pmid: 16356779
references.citation: Life Sci. 2004 Aug 20;75(14):1659-99
references.pmid: 15268969
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1023-6
references.pmid: 17433517
references.citation: Biol Psychiatry. 2005 May 1;57(9):1068-72
references.pmid: 15860348
references.citation: Behav Brain Res. 2008 Dec 1;194(1):108-13
references.pmid: 18655806